Now, keep up to date
with daily feeds of newly posted stories
about America's Seniors...click on the box
to the left
Lifestyle intervention for overweight
patients with Diabetes provides long-term
benefits
September 2010--An intensive lifestyle
intervention appears to help individuals
with type 2 diabetes lose weight and keep it
off, along with improving fitness, control
of blood glucose levels and risk factors for
cardiovascular disease, according to a
report in the September 27 issue of Archives
of Internal Medicine, one of the JAMA/Archives
journals.
Improving blood glucose control and
cardiovascular risk factors in patients with
type 2 diabetes is critical in preventing
long-term complications of the disease,
according to background information in the
article.
Emphasis has been placed on screening and
pharmacologic management of these
parameters.
"Lifestyle-based weight loss interventions are
also recommended to improve glycemic control
and risk factors, but the evidence
supporting the efficacy of lifestyle
approaches is limited to short-term studies
of typically less than one year," the
authors write.
The Look AHEAD (Action for Health in Diabetes)
Research Group conducted a multicenter
randomized clinical trial comparing the
effects of an intensive lifestyle
intervention to diabetes support and
education among 5,145 overweight or obese
individuals (average age 58.7) with type 2
diabetes.
Of these, 2,570 were assigned to the lifestyle
intervention, a combination of diet
modification and physical activity designed
to induce a 7 percent weight loss in the
first year and maintain it in subsequent
years.
Participants were seen and contacted by phone
at least monthly for all four years. The
2,575 individuals assigned to the diabetes
support and education group were invited to
three group sessions each year focusing on
diet, physical activity and social support.
On average, across the four-year period,
individuals in the lifestyle intervention
group lost a significantly larger percentage
of their weight than did those in the
diabetes support group (6.2 percent vs. 0.9
percent).
They also experienced greater improvements in
fitness, hemoglobin A1c level (a measure of
blood glucose), blood pressure and levels of
high-density lipoprotein (HDL, or "good"
cholesterol). Individuals in the diabetes
support group, on the other hand,
experienced greater reductions in
low-density lipoprotein (LDL, or "bad")
cholesterol, owing to greater use of
cholesterol-lowering medications in this
group.
At the end of four years, the lifestyle
intervention group maintained greater
improvements in weight, fitness, hemoglobin
A1c levels, systolic (top number) blood
pressure and HDL levels.
"Although the differences between the two
groups were greatest initially and decreased
over time for several measures, the
differences between the groups averaged
across the four years were substantial and
indicate that the intensive lifestyle
intervention group spent a considerable time
at lower cardiovascular disease risk," the
authors write.
"The critical question is whether the
differences between groups in risk factors
will translate into differences in the
development of cardiovascular disease," they
continue.
"These results will not be available for
several additional years. However, effects
of the magnitude that we observed for
fitness, HDL-C and hemoglobin A1c levels and
blood pressure have been associated with
decreased cardiovascular events and
mortality in previous medication trials and
observational studies. Moreover, there may
be long-term beneficial effects from the
four-year period in which intensive
lifestyle intervention participants have
been exposed to lower cardiovascular disease
risk factors, as seen in other clinical
trials."